Finance

Lists
IMMX:NASDAQ
Immix Biopharma Inc
7,04 $
0,00%
(0,00) 1D
20 նոյ, 15:19:09 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMMX...
Open
7,00 $
High
7,50 $
Low
6,90 $
Mkt. cap
590,04 մլն
Avg. vol.
1,19 մլն
Volume
1,04 մլն
52-wk high
15,10 $
52-wk low
3,78 $
EPS
-0,82 $
Beta
0,29
Shares outstanding
83,81 մլն
No. of employees
21
Open
7,00 $
High
7,50 $
Low
6,90 $
Mkt. cap
590,04 մլն
Avg. vol.
1,19 մլն
Volume
1,04 մլն
52-wk high
15,10 $
52-wk low
3,78 $
EPS
-0,82 $
Beta
0,29
Shares outstanding
83,81 մլն
No. of employees
21
News stories
From web sources and news partners
About Immix Biopharma Inc
CEO-
Employees21
Founded2012
HeadquartersԼոս Անջելես, Կալիֆոռնիա, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Analyst ratings
Based on 6 analysts giving stock ratings to IMMX in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for IMMX in the last 3 months.
Highest
Current 7,04 $
30,00 $ (+326,14%)
Average
25,67 $ (+264,63%)
Lowest
21,00 $ (+198,30%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sean Laaman
Morgan Stanley
Buy
Reiterated
21,00 $
+198,3%
11/18/2026
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
22,00 $
+212,5%
11/18/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
27,00 $
+283,5%
11/16/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
20,00 $
+184,1%
10/20/2026
Patrick Dolezal
LifeSci Capital
Buy
Maintained
24,00 $
+240,9%
10/03/2026
Gil Blum
Needham
Buy
Reiterated
30,00 $
+326,1%
09/29/2026
Tazeen Ahmad
Bank of America Securities
Buy
Reiterated
30,00 $
+326,1%
09/29/2026
Reni Benjamin
Citizens JMP
Buy
Initiated
23,00 $
+226,7%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5,73 մլն
5,98 մլն
5,33 մլն
5,54 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,17 մլն
4,82 մլն
7,12 մլն
10,40 մլն
Operating expense
10,89 մլն
10,80 մլն
12,46 մլն
15,95 մլն
Total operating expenses
10,89 մլն
10,80 մլն
12,46 մլն
15,95 մլն
Operating income
-10,89 մլն
-10,80 մլն
-12,46 մլն
-15,95 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-10,68 մլն
-10,09 մլն
-11,54 մլն
-13,93 մլն
EBT excluding unusual items
-10,68 մլն
-10,09 մլն
-11,54 մլն
-13,93 մլն
Income tax expense
11,27 հզր
-
14,32 հզր
-
Effective tax rate
-0,11%
-
-0,12%
-
Other operating expenses
-
-
-
-
Net income
-10,69 մլն
-10,09 մլն
-11,56 մլն
-13,93 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,28
-0,18
-0,18
-0,19
Interest and investment income
216,71 հզր
717,17 հզր
913,66 հզր
2,02 մլն
Interest expense
-
-
-
-
Net interest expenses
216,71 հզր
717,17 հզր
913,66 հզր
2,02 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-10,84 մլն
-10,71 մլն
-12,37 մլն
-15,85 մլն
Gain or loss from assets sale
-
34,15 հզր
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps